Figure 3From: Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia Source of information for ESCARVAL-RISK study: ABUCASIS Clinical record system: A patient's record.Back to article page